Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 12, 2005, Pages 1079-1085

  Xian, Junming ^a   Yang, Huan ^c   Lin, Yinghe ^b   Liu, Shixi ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Food and Drug Administration   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXTERNAL BEAM RADIOTHERAPY; GENE THERAPY; HEAD AND NECK CARCINOMA; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MOUTH; NATURAL KILLER CELL; NONHUMAN; TUMOR LOCALIZATION;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEAD AND NECK NEOPLASMS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; NECROSIS; RADIOTHERAPY; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 29144512421     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.131.12.1079     Document Type: Article

References (19)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 1999;49:8-31.
2. Mandpe AH, Tsung K, Norton JA. Cure of an established nonimmunogenic tumor, SCC VII,with a novel interleukin 12-based immunotherapy regimen in C3H mice. Arch Otolaryngol Head Neck Surg. 2003;129:786-792.
3. Bray D, Yu S-Z, O'Malley BW Jr, et al. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129:618-622.
4. Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer. 1997;80(12, suppl):2519-2528.
5. Ettinger DS. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer. Semin Radiat Oncol. 1999;9(suppl 1):148-150.
6. O'Malley BW Jr, Daqing L, Dunno DUH, et al. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer. Laryngoscope. 2005;115:391-404.
7. Wigginton JM, Konschlies KL, Back TC, et al. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst. 1996;88:38-43.
8. O'Malley BW Jr, Cope KA, Johnson CS, et al. A new immunocompetent murine model for oral cancer. Arch Otolaryngol Head Neck Surg. 1997;123:20-24.
9. Li D, Zeiders JW, Liu S, et al. Combination nonviral cytokine gene therapy for head and neck cancer. Laryngoscope. 2001;111:815-820.
10. Atkinson G, Hall SJ. Prodrug activation gene therapy and external irradiation in the treatment of prostate cancer. Urology. 1999;54:1098-1104.
11. Rashleigh SP, Kusher DI, Endicott JN, et al. Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122:541-547.
12. Kimura Y, Mizuno H, Statake K, et al. Effects of combined therapy with interleukin 2 and interleukin 12 gene-transfected tumor vaccine for head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:1181-1185.
13. Nastala CL, Edington HD, Mc Kinney TG, et al. Recombinant IL-12 administration induces tumor regression in association with INF-γ production. J Immunol. 1994;153:1697-1706.
14. Gately MK, Warrier RR, Honasoge S, et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of INF-γ in vivo. Int Immunol. 1994;6:157-167.
15. Cui J, Shin T, Kawano T, et al. Requirement for VαNKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623-1626.
16. Kitamura H, Iwakabe K, Yahata T, et al. The natural killer T NKT cell ligand aiphagalactosylceramide demonstrates its immunopotentiating effect by inducing interleukin-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med. 1999;189:1121-1128.
17. Dezso B, Haas GP, Hamzavi F, et al. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res. 1996;2:1543-1552.
18. Younes E, Haas GP, Dezso B, et al. Radiation-induced effects on murine kidney tumor cells: role in the interaction of local irradiation and immunotherapy. J Urol. 1995;153:2029-2033.
19. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: current status and future prospects. Thyroid. 2004;14:424-434.